Murciano-Goroff, Y. R., LoRusso, P., Garrido-Laguna, I., Herzberg, B., Patnaik, A., Gandhi, N. J., Smith, K., Cykowski, L., Zhi, X., Healey, D. I., Patel, V. G., Hong, D. S. (2026). Phase 1/2 study of ARV-806, a PROTAC KRAS G12D degrader, in
                    <i>KRAS</i>
                    G12D–mutated advanced solid tumors, including pancreatic cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.tps792